Reducing blood glucose in T1DM is necessary to avoid side effects such as neuropathy, glaucoma, nephropathy, and cardiomyopathy (37-40), for which the most popular treatment is insulin injection, although this is not very practical. This evidence concerns the gene INS and cardiomyopathy.